Since IL-22 has been shown to have therapeutic potential by decreasing lung inflammation and injury in a murine model of H1N1 influenza [17], we hypothesized that the IL-22 protein given after acute lung injury (ALI) in mice would mitigate inflammation and repair ARDS-associated lung injury. Here, IL22 is linked to acute respiratory distress syndrome.